Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.53 |
| ▸ | PLK1 | P53350 | 1/20 | 0.48 |
| ▸ | RAB9A | P51151 | 1/20 | 0.48 |
| ▸ | LTA4H | P09960 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.44 |
| ▸ | ESR1 | P03372 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | ACACB | O00763 | 3/20 | 0.41 |
| ▸ | ACACA | Q13085 | 3/20 | 0.41 |
| ▸ | PCNA | P12004 | 1/20 | 0.41 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | GLA | P06280 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | CASP1 | P29466 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6135975 | 0.95 | MAPT (0.53) | MAPTRAB9ALTA4HESR1TSHR | |
| SCHEMBL6135858 | 0.89 | MAPT (0.47) | MAPTPLK1RAB9ALTA4HTDP1 | |
| SCHEMBL6725224 | 0.86 | KMT2A (0.52) | PLK1LTA4HL3MBTL1PLA2G2ATSHR | |
| SCHEMBL237992 | 0.83 | CA1 (0.58) | MAPTL3MBTL1TDP1PCNAKDM4E | |
| SCHEMBL6136142 | 0.83 | POLB (0.44) | MAPTL3MBTL1TDP1PCNAKDM4E | |
| SCHEMBL6135981 | 0.81 | PCNA (0.56) | L3MBTL1TDP1PCNAKDM4EGAA | |
| SCHEMBL6723520 | 0.81 | TP53 (0.57) | LTA4HPLA2G2ATSHR | |
| SCHEMBL6135987 | 0.80 | TSHR (0.52) | MAPTRAB9AL3MBTL1TDP1KDM4E | |
| SCHEMBL2341097 | 0.79 | MAPT (0.82) | MAPTPLK1RAB9AL3MBTL1TDP1 | |
| Methylamine SCHEMBL2429643 | 0.76 | MAPT (0.77) | MAPTPLK1RAB9AL3MBTL1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250346549-A2 | NOVEL AROMATIC MOLECULES | Xeniopro GmbH (DE) | 2025-11-13 | — | — | US | disclosed |
| US-20250084023-A2 | NOVEL AROMATIC MOLECULES | Xeniopro GmbH (DE) | 2025-03-13 | — | — | US | disclosed |
| US-20240140895-A1 | NOVEL AROMATIC MOLECULES | Xeniopro GmbH (DE) | 2024-05-02 | — | — | US | disclosed |
| EP-0954299-B1 | THYROXINE ANALOGUES HAVING NO SIGNIFICANT HORMONAL ACTIVITY FOR TREATING MALIGNANT TUMOURS | OCTAMER INC (US) | 2005-07-27 | — | — | EP | disclosed |
| US-6326402-B1 | AROMATIC ESTER COMPOUND | OCTAMER, INC. | 2001-12-04 | — | — | US | disclosed |
| EP-0954299-A4 | METHOD OF TREATING MALIGNANT TUMORS WITH THYROXINE ANALOGUES HAVING NO SIGNIFICANT HORMONAL ACTIVITY | OCTAMER INC (US) | 2000-09-06 | — | — | EP | disclosed |
| WO-2000009114-A1 | METHODS FOR TREATING VIRAL INFECTIONS USING A COMPOUND CAPABLE OF INHIBITING MICROTUBULES | OCTAMER, INC. (US) | 2000-02-24 | — | — | WO | disclosed |
| US-6017958-A | A THERAPEUTIC TREATMENT USING A METHYL ALKYLOXY- OR THIO-PHENYL BENZOATE, AS POTENT, SELECTIVE AND NON-TOXIC ANTI-TUMOR AGENTS FOR TREATING CANCER | OCTAMER, INC. (US) | 2000-01-25 | — | — | US | disclosed |
| EP-0954299-A1 | METHOD OF TREATING MALIGNANT TUMORS WITH THYROXINE ANALOGUES HAVING NO SIGNIFICANT HORMONAL ACTIVITY | Octamer, Inc. (US) | 1999-11-10 | — | — | EP | disclosed |
| WO-1997046228-A9 | METHOD OF TREATING MALIGNANT TUMORS WITH THYROXINE ANALOGUES HAVING NO SIGNIFICANT HORMONAL ACTIVITY | — | 1998-04-23 | — | — | WO | disclosed |
| US-5736576-A | ADMINISTERING METHYL 3,5-DIIODO-4-(4*-METHOXYPHENOXY)BENZOATE | OCTAMER, INC. (US) | 1998-04-07 | — | — | US | disclosed |
| WO-1997046228-A1 | METHOD OF TREATING MALIGNANT TUMORS WITH THYROXINE ANALOGUES HAVING NO SIGNIFICANT HORMONAL ACTIVITY | OCTAMER, INC. (US) | 1997-12-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250084023-A2 | NOVEL AROMATIC MOLECULES | AHR, TYR, MUSK | MAPT 2300/4885PLK1 3220/4885RAB9A 2960/4885 |
| US-20250346549-A2 | NOVEL AROMATIC MOLECULES | AHR, TYR, MUSK | MAPT 2300/4885PLK1 3220/4885RAB9A 2960/4885 |
| US-20240140895-A1 | NOVEL AROMATIC MOLECULES | AHR, TYR, MUSK | MAPT 2300/4885PLK1 3220/4885RAB9A 2960/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.